IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $886,000 | -14.6% | 92,500 | -1.6% | 0.36% | -11.9% |
| Q2 2022 | $1,038,000 | -34.0% | 94,000 | -0.5% | 0.41% | -24.2% |
| Q1 2022 | $1,573,000 | -12.8% | 94,500 | 0.0% | 0.54% | +1.3% |
| Q4 2021 | $1,804,000 | -22.6% | 94,500 | 0.0% | 0.54% | -23.4% |
| Q3 2021 | $2,330,000 | -8.1% | 94,500 | -3.0% | 0.70% | -18.8% |
| Q2 2021 | $2,535,000 | +10.9% | 97,444 | +35.0% | 0.86% | +32.9% |
| Q1 2021 | $2,285,000 | -28.8% | 72,168 | +4.3% | 0.65% | -27.1% |
| Q4 2020 | $3,209,000 | +729.2% | 69,168 | +488.7% | 0.89% | +616.1% |
| Q3 2020 | $387,000 | +779.5% | 11,750 | +135.0% | 0.12% | +726.7% |
| Q4 2018 | $44,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |